NO20044564L - Fremgangsmater for behandling av nekrotiserende enterocolit - Google Patents

Fremgangsmater for behandling av nekrotiserende enterocolit

Info

Publication number
NO20044564L
NO20044564L NO20044564A NO20044564A NO20044564L NO 20044564 L NO20044564 L NO 20044564L NO 20044564 A NO20044564 A NO 20044564A NO 20044564 A NO20044564 A NO 20044564A NO 20044564 L NO20044564 L NO 20044564L
Authority
NO
Norway
Prior art keywords
methods
necrotizing enterocolitis
treating necrotizing
treating
patient
Prior art date
Application number
NO20044564A
Other languages
English (en)
Norwegian (no)
Inventor
Leo E Otterbein
Brian Zuckerbraun
Original Assignee
Univ Pittsburg Of The Commonwe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburg Of The Commonwe filed Critical Univ Pittsburg Of The Commonwe
Publication of NO20044564L publication Critical patent/NO20044564L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
NO20044564A 2002-04-15 2004-10-22 Fremgangsmater for behandling av nekrotiserende enterocolit NO20044564L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37259902P 2002-04-15 2002-04-15
PCT/US2003/011167 WO2003088981A1 (fr) 2002-04-15 2003-04-15 Methodes de traitement de l'enterocolite necrosante neonatale

Publications (1)

Publication Number Publication Date
NO20044564L true NO20044564L (no) 2004-11-18

Family

ID=29250879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044564A NO20044564L (no) 2002-04-15 2004-10-22 Fremgangsmater for behandling av nekrotiserende enterocolit

Country Status (15)

Country Link
US (1) US7981448B2 (fr)
EP (1) EP1499328B1 (fr)
JP (1) JP4585765B2 (fr)
CN (1) CN1652802A (fr)
AU (1) AU2003223562B2 (fr)
CA (1) CA2481786A1 (fr)
EA (1) EA200401366A1 (fr)
ES (1) ES2554108T3 (fr)
HR (1) HRP20040973A2 (fr)
MX (1) MXPA04010242A (fr)
NO (1) NO20044564L (fr)
PL (1) PL374241A1 (fr)
RS (1) RS91104A (fr)
UA (1) UA86570C2 (fr)
WO (1) WO2003088981A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
BR0210599A (pt) * 2001-06-21 2004-07-20 Beth Israel Hospital Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
US7011854B2 (en) 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
EP1499328B1 (fr) 2002-04-15 2015-09-16 University of Pittsburgh - Of the Commonwealth System of Higher Education Methodes de traitement de l'enterocolite necrosante neonatale
CN100496509C (zh) 2002-04-15 2009-06-10 联邦高等教育系统匹兹堡大学 一氧化碳产品及其对于肠梗阻的用途
WO2003088748A1 (fr) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Utilisation d'heme-oxygenase-1 et produits de degradation d'heme
JP4549847B2 (ja) 2002-05-17 2010-09-22 イエール ユニバーシティ 肝炎の治療方法
WO2003103585A2 (fr) * 2002-06-05 2003-12-18 Yale University Methodes de traitement de l'angiogenese, de la croissance tumorale et de metastases
RS110504A (en) * 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CN1719975A (zh) * 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗
AU2004283729A1 (en) 2003-10-22 2005-05-06 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells
JPWO2007073006A1 (ja) * 2005-12-22 2009-06-04 学校法人慶應義塾 細胞保護性を有するアミノ酸の増加誘導剤及び増加方法
DE102008037168A1 (de) * 2008-08-06 2010-06-24 Nowak, Götz, Prof. Dr. Verwendung von Sauerstoff zur Behandlung von Erkrankungen der Schleimhaut des Magen-Darm-Kanals
SI3498328T1 (sl) 2009-05-27 2021-03-31 Mallinckrodt Hospital Products IP Limited Pripomoček za spajanje indeksiranega ventila in sestava posode pod tlakom s pritrdilnim obročem in za linearno sprožitev sestava sprožilnika pri odvajanju tekočin s pripomočkom za reguliranje dovajanja zdravila
CA2671029A1 (fr) 2009-06-30 2010-12-30 James S. Baldassarre Procedes destines au traitement des nouveau-nes a terme ou presque a terme atteints d'une insuffisance respiratoire hypoxique associee a des signes cliniques ou echocardiographiques d'hypertension pulmonaire
EP3583851A1 (fr) * 2011-01-14 2019-12-25 Children's Hospital Los Angeles Solution de monoxyde de carbone utilisable en vue du traitement d'une maladie, notamment la drépanocytose
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
CA2844660A1 (fr) * 2011-08-09 2013-02-14 Leo E. Otterbein Procede de traitement d'un dommage a l'adn
CN103263715B (zh) * 2013-05-24 2015-12-02 史源 一氧化碳吸入仪
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
ES2930351T3 (es) 2016-04-15 2022-12-09 Evive Biotechnology Shanghai Ltd Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5180366A (en) 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5293875A (en) 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
ATE264671T1 (de) 1993-02-22 2004-05-15 American Bioscience Inc Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
EP0804244A1 (fr) 1993-03-26 1997-11-05 Biorelease Technologies, Inc. Compositions comportant des proteines heminiques et methodes associees
US5763431A (en) 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US5712293A (en) 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
US5731326A (en) 1995-06-30 1998-03-24 Zymogenetics, Inc. PDGF antagonists II
AU720686B2 (en) * 1996-04-05 2000-06-08 General Hospital Corporation, The Treatment of a hemoglobinopathy
US6069132A (en) 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
PT921807E (pt) 1996-08-27 2004-04-30 Messer Griesheim Gmbh Medicamentos contendo hidrogenio
US6316403B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
EP0951292B1 (fr) 1996-09-27 2007-04-04 The Trustees of Columbia University in the City of New York Traitement d'un trouble ischemique et d'amelioration de l'etat a l'issue d'une attaque
TR200101501T2 (tr) 1998-03-16 2002-06-21 Celgene Corporation 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı.
US6203991B1 (en) 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US20050250688A1 (en) 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
BR0208012A (pt) 2001-03-20 2004-03-02 Glaxo Group Ltd Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
CN1507348A (zh) 2001-03-30 2004-06-23 ɣ����ҽҩ��˾ 用于治疗血管性、炎性和免疫疾病的一氧化碳生成性组合物
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
DE60202677T2 (de) 2001-05-25 2005-12-29 Medtronic, Inc., Minneapolis Implantierbare medizinische vorrichtung mit kontrollierter freigabe von gasförmigen mitteln
BR0210599A (pt) 2001-06-21 2004-07-20 Beth Israel Hospital Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
US7011854B2 (en) 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US7364757B2 (en) 2002-02-13 2008-04-29 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating vascular disease
CN100496509C (zh) 2002-04-15 2009-06-10 联邦高等教育系统匹兹堡大学 一氧化碳产品及其对于肠梗阻的用途
EP1499328B1 (fr) 2002-04-15 2015-09-16 University of Pittsburgh - Of the Commonwealth System of Higher Education Methodes de traitement de l'enterocolite necrosante neonatale
WO2003088748A1 (fr) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Utilisation d'heme-oxygenase-1 et produits de degradation d'heme
RS96904A (en) 2002-05-09 2007-02-05 Yale University, Carbon monoxide as a biomarker and therapeutic agent
JP4549847B2 (ja) 2002-05-17 2010-09-22 イエール ユニバーシティ 肝炎の治療方法
WO2003103585A2 (fr) 2002-06-05 2003-12-18 Yale University Methodes de traitement de l'angiogenese, de la croissance tumorale et de metastases
RS110504A (en) 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
CN1719975A (zh) 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗
WO2005077005A2 (fr) 2004-02-04 2005-08-25 The General Hospital Corporation Amelioration de l'efficacite d'un gaz therapeutique inhale

Also Published As

Publication number Publication date
HRP20040973A2 (en) 2005-06-30
ES2554108T3 (es) 2015-12-16
CA2481786A1 (fr) 2003-10-30
JP2005530737A (ja) 2005-10-13
AU2003223562B2 (en) 2009-04-09
EP1499328B1 (fr) 2015-09-16
EA200401366A1 (ru) 2006-02-24
AU2003223562A1 (en) 2003-11-03
US20040005367A1 (en) 2004-01-08
MXPA04010242A (es) 2005-06-08
UA86570C2 (ru) 2009-05-12
WO2003088981A1 (fr) 2003-10-30
RS91104A (en) 2007-02-05
JP4585765B2 (ja) 2010-11-24
PL374241A1 (en) 2005-10-03
EP1499328A1 (fr) 2005-01-26
CN1652802A (zh) 2005-08-10
EP1499328A4 (fr) 2008-03-26
US7981448B2 (en) 2011-07-19

Similar Documents

Publication Publication Date Title
NO20044564L (no) Fremgangsmater for behandling av nekrotiserende enterocolit
NO20044562L (no) Fremgangsmater for behandling av tarmslyng
NO20045056L (no) Fremgangsmater for behandling av hepatitt
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
NO20050607L (no) Fremgangsmate og innretning for tildeling av CO
TW200626160A (en) Memantine for the treatment of childhood behavioral disorders
NO20045354L (no) Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
NO20063304L (no) Fremgangsmate til a rense FSH
EP1728517A3 (fr) Methodes de traitement de troubles des glandes mammaires
WO2008079270A3 (fr) Coadministration d'alpha-foetoprotéine et d'un agent immunomodulateur pour traiter la sclérose en plaques
WO2003104425A3 (fr) Nouveaux anticorps anti-cd22 stables
DE602006014009D1 (de) Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
WO2006042745A3 (fr) Analogues de peptides modifies chimiquement
WO2006110724A3 (fr) Methode de traitement d'un prodrome schizophrenique
NO20051390L (no) Fremgangsmate for behandling av pasienter med massivt blodtap
WO2008059041A3 (fr) Complémentation d'un déficit de facteur xi par mutants de facteur v
WO2006091544A3 (fr) Procedes et compositions de modulation des canaux calciques
GB0701103D0 (en) Software duplication
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60322395D1 (de) Antipruritisches mittel
WO2007010013A3 (fr) Composes organiques
DK1503803T3 (da) Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps
AU2003222462A1 (en) Method of performing soojichim acupuncture using bodycopy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application